Innovation Pharmaceuticals Inc (IPIX)

[frrol]

The clinical failure of P was anticipated by the market. The market also has a low opinion of B and K, and the skepticism is understandable. Nevertheless, those compounds are still viable and the company claims to have a term sheet in place for licensing part of B. Since the failure of P was broadly anticipated, the news didn't immediately affect share price much. What it did was reduce the view of potential return to those like me who thought P had a chance of succeeding. It also increased the need for a B deal, since P will no longer attract deal capital.

So that's where we are: waiting to hear about a B deal. It's not about manipulators or shorts or "management knows what we have". I hope folks have seen the foolishness of conspiracy theories, confirmation bias, and pumping.

Based on this low market cap, the market doesn't think we're getting a B deal. An investment in IPIX is a risk that, while the market is usually right, it's wrong about that one. GLTA, hopefully we hear soon about a deal We have limited capital.